Roy Fried. Show Affiliations »
Abstract
Mesh： See more » Age FactorsAgedAged, 80 and overHerpes Zoster/epidemiologyHerpes Zoster/prevention & controlHerpes Zoster Vaccine/administration & dosageHerpesvirus 3, Human/immunologyHumansIncidenceMiddle AgedQuality of LifeRisk FactorsTreatment OutcomeUnited States/epidemiologyVaccination
Substances： See more » Herpes Zoster Vaccine
Year: 2010 PMID： 20863342 DOI： 10.1111/j.1532-5415.2010.03023.x
Source DB: PubMed Journal: J Am Geriatr Soc ISSN： 0002-8614 Impact factor: 5.562